Hankey Capital
Late Stage
What they invest in
from 1 of 1 portfolio companiesBiotech Γ1
HQs:United StatesΓ1
Investments Β· 1 tracked
founders shown can be your intro pathBiotechBoston, US
Jeff Frelick(Executive Officer)Deina Walsh(Executive Officer)inSteve La Neve(Executive Officer)Chia Soo(Director)Benjamin Wu(Director)
BoardBruce Stroever(Director)
Exits Β· 1
IPOs and acquisitions across the tracked portfolioBone BiologicsNASDAQ: BBLG
Portfolio news
latest coverage across their companiesBone Biologics Β· stocktitan.net Β· Jul 23, 2026
Frequently asked questions
- What stage does Hankey Capital invest at?
- Hankey Capital invests at the Late Stage stage.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.


